Ro, a direct-to consumer telehealth company, raised $88m in Series A funding.
The round, which brought total funding to $91.1m, was led by FirstMark Capital with participation from SignalFire, Initialized Capital, General Catalyst, Slow Ventures, Sinai Ventures, Torch Capital, BoxGroup and Tusk Ventures.
In conjunction with the funding, FirstMark Managing Director Rick Heitzmann joined Ro’s board of directors, along with Alexis Ohanian, Initialized Capital.
The company intends to use the funds to continue to expand its offerings and operations.
Co-founded in 2017 by Rob Schutz, Saman Rahmanian and Zachariah Reitano, Ro created a first vertical with Roman, an end-to-end service for men’s health, starting with erectile dysfunction, followed by Zero, an end-to-end service to fight addiction, starting with smoking cessation. With Ro, members experience discreet and safe online platforms to get help from diagnosis, to prescription, to delivery and beyond.
Zero enables users to track their progress, see how their body is improving, and read personalized physician treatment guides. The app will be available for free on iOS, with Android soon to launch.
The Quit Kit includes a combination of bupropion, a prescription medication to help smokers control smoking cravings, and nicotine gum, a form of NRT, paired alongside an app. The Gum, Rx and app are also available individually.